Abeome Corporation, Athens, Georgia, USA.
Stem Cells Dev. 2011 Mar;20(3):515-25. doi: 10.1089/scd.2010.0172. Epub 2010 Nov 8.
Hesca-2, a monoclonal antibody (mAb) IgM raised to the human embryonic stem cell (hESC) line BG-01v, binds with high affinity (nM) to the disaccharide epitope (Galβ1-3GlcNAc) on a glycan microarray. This epitope was expressed on pluripotent progenitor hESCs in culture, but not in various differentiated cells derived from hESC based on immunofluorescence microscopy. Hesca-2 stains a limited subset of cells in adult human tissues (eg, esophagus and breast). This mAb also crossreacts in immunofluorescence microscopy studies with several human ovarian cancer cell lines and is cytotoxic to them based on the release of cytosolic enzyme lactate dehydrogenase into the media. Hesca-2 immunohistochemically stained tissue from a number of human tumors, including ovary, breast, colon, and esophageal cancer. These data suggest that Hesca-2 recognizes a surface marker found both in stem cells and certain cancer cells.
Hesca-2 是一种针对人胚胎干细胞 (hESC) 系 BG-01v 产生的单克隆抗体 (mAb) IgM,与聚糖微阵列上的二糖表位 (Galβ1-3GlcNAc) 具有高亲和力 (nM)。该表位在培养中的多能祖 hESC 中表达,但在基于免疫荧光显微镜的各种源自 hESC 的分化细胞中不表达。Hesca-2 可在成人组织中的有限亚群细胞(例如食管和乳腺)中染色。该 mAb 在免疫荧光显微镜研究中还与几种人卵巢癌细胞系发生交叉反应,并且基于细胞质酶乳酸脱氢酶释放到培养基中,对它们具有细胞毒性。Hesca-2 免疫组化染色了来自多种人类肿瘤的组织,包括卵巢癌、乳腺癌、结肠癌和食管癌。这些数据表明 Hesca-2 识别存在于干细胞和某些癌细胞中的表面标记物。